Emergency integrative supportive care program for frail patients with advanced pancreatic cancer: A prospective GERCOR ARCAD study
Benoı̂t Rousseau, Marc Hilmi, Antoine Falcoz, Dewi Vernerey et autres
0 citationsmedRxiv
Marie‐Line Garcia‐Larnicol
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
31Publications signalées
836Citations signalées
4Affiliations récentes
Institutions déclarées
Domaines associés
Colorectal Cancer Treatments and StudiesCancer Immunotherapy and BiomarkersPancreatic and Hepatic Oncology ResearchColorectal Cancer Surgical TreatmentsGastric Cancer Management and Outcomes
Publications récentes
Circulating tumour DNA in patients with colorectal cancer undergoing curative-intent LIver MEtastases Surgery in France: a prospective, multicentre GERCOR G-118 CLIMES PRODIGE 77 cohort study protocol
Andrius Meskauskas, Romain Cohen, Dewi Vernerey, Jean‐Baptiste Bachet et autres
0 citationsBMJ Open
Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in patients with localized microsatellite instability-high (MSI)/mismatch repair deficient (dMMR) oeso-gastric adenocarcinoma: Long-term follow-up of the GERCOR NEONIPIGA phase II study.
Thomas Samaille, Julie Henriques, David Tougeron, Guillaume Piessen et autres
1 citationJournal of Clinical Oncology
STRATEGIC-1: multiple-line, randomized, open-label GERCOR-PRODIGE-39 phase III trial in unresectable RAS/BRAF wild-type metastatic colorectal cancer
Benoist Chibaudel, Louis-Marie Dourthe, Thierry André, Julie Henriques et autres
0 citationsSignal Transduction and Targeted Therapy
Sunitinib as Second‐Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN ‐ CK GERCOR Phase II Trial
Louis Gros, Mohamed Bouattour, Clément Dumont, Laëtitia Dahan et autres
6 citationsLiver International
Maintenance with OSE2101 plus FOLFIRI vs FOLFIRI alone after FOLFIRINOX (FFX) induction in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): Primary endpoint results of a randomized TEDOPAM GERCOR D17-01 PRODIGE 63 trial.
Anthony Turpin, Emmanuel Mitry, Olivier Bouché, Yves Rinaldi et autres
3 citationsJournal of Clinical Oncology
Optimization of intra-peritoneal chemotherapy: Randomized phase II GERCOR CHIMOVIP study.
Romain Cohen, Nadia Raban, Déwi Vernerey, Cyrille Huchon et autres
0 citationsJournal of Clinical Oncology
Assessment of an emergency 14-day (d) integrative supportive care program (14-EISCP) followed by early chemotherapy (CTx) in symptomatic patients (pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): A prospective ARCAD cohort study.
Benoı̂t Rousseau, Antoine Falcoz, Clémence Toullec, Thierry Lecomte et autres
2 citationsJournal of Clinical Oncology
Targeting the Tumor Microenvironment through mTOR Inhibition and Chemotherapy as Induction Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma: The CAPRA Study
Diane Evrard, Clément Dumont, Michel Gatineau, Jean‐Pierre Delord et autres
9 citationsCancers
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability–High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II Study
Thierry André, David Tougeron, Guillaume Piessen, Christelle de la Fouchardière et autres
402 citationsJournal of Clinical Oncology
A randomized, non-comparative, phase II study of maintenance OSE2101 vaccine alone or in combination with nivolumab (nivo) or FOLFIRI after induction with FOLFIRINOX in patients (Pts) with advanced pancreatic ductal adenocarcinoma (aPDAC): First interim results of the TEDOPAM GERCOR D17-01 PRODIGE 63 STUDY.
Marc Hilmi, Emmanuel Mitry, Anthony Turpin, Olivier Bouché et autres
3 citationsJournal of Clinical Oncology
Durvalumab (D) plus tremelimumab (T) immunotherapy in patients (Pts) with advanced biliary tract carcinoma (BTC) after failure of platinum-based chemotherapy (CTx): Interim results of the IMMUNOBIL GERCOR D18-1 PRODIGE-57 study.
Matthieu Delaye, Éric Assenat, Laëtitia Dahan, Jean‐Frédéric Blanc et autres
11 citationsJournal of Clinical Oncology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.